Endothelial Function is Not Changed during Short-Term Withdrawal of Thyroxine in Patients with Differentiated Thyroid Cancer and Low Cardiovascular Risk
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: The incidence of differentiated thyroid cancer is increasing in young adults and females in Korea. Some of them experience short-term hypothyroidism in preparation for radioiodine (RAI) therapy, which can have a deleterious effect on the cardiovascular system. However, it is not clear if short-term hypothyroidism induces endothelial dysfunction in patients with low cardiovascular risk. Therefore,the aim of this study was to investigate whether short-term hypothyroidism is associated with endothelial dysfunction in patients with low cardiovascular risk. Materials and Methods: To evaluate the effect of short-term hypothyroidism on endothelial function in this group, we recruited fifteen female patients with low cardiovascular risk. We analyzed clinical, biochemical, and cardiovascular parameters at four time points: the last day on levothyroxine (LT4) at their usual thyroid-stimulating hormone (TSH)-suppressive doses (P1), 7 days (P2) & 4 weeks (P3) after withdrawal of LT4, and 8 weeks (P4) after replacement of the previous dose of LT4. A high resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperemia, and after sublingual nitroglycerin. Results: During short-term hypothyroidism (P3), serum concentrations of total cholesterol and low-density lipoprotein (LDL)-cholesterol were increased (p <0.001 for each period). In spite of having worsened lipid states, serum high sensitivity C-reactive protein or flow-mediated vasodilatation, which is one of the surrogate markers of the endothelial function, did not change during short-term hypothyroidism. Conclusion: Short-term hypothyroidism induced worsening of metabolic parameters, but not enough to induce the endothelial dysfunction in patients with low cardiovascular risk.
Abstract
Purpose: The incidence of differentiated thyroid cancer is increasing in young adults and females in Korea. Some of them experience short-term hypothyroidism in preparation for radioiodine (RAI) therapy, which can have a deleterious effect on the cardiovascular system. However, it is not clear if short-term hypothyroidism induces endothelial dysfunction in patients with low cardiovascular risk. Therefore,the aim of this study was to investigate whether short-term hypothyroidism is associated with endothelial dysfunction in patients with low cardiovascular risk. Materials and Methods: To evaluate the effect of short-term hypothyroidism on endothelial function in this group, we recruited fifteen female patients with low cardiovascular risk. We analyzed clinical, biochemical, and cardiovascular parameters at four time points: the last day on levothyroxine (LT4) at their usual thyroid-stimulating hormone (TSH)-suppressive doses (P1), 7 days (P2) & 4 weeks (P3) after withdrawal of LT4, and 8 weeks (P4) after replacement of the previous dose of LT4. A high resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperemia, and after sublingual nitroglycerin. Results: During short-term hypothyroidism (P3), serum concentrations of total cholesterol and low-density lipoprotein (LDL)-cholesterol were increased (p <0.001 for each period). In spite of having worsened lipid states, serum high sensitivity C-reactive protein or flow-mediated vasodilatation, which is one of the surrogate markers of the endothelial function, did not change during short-term hypothyroidism. Conclusion: Short-term hypothyroidism induced worsening of metabolic parameters, but not enough to induce the endothelial dysfunction in patients with low cardiovascular risk.
참고문헌 (30)
- Pacini F, "European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium", Eur J Endocrinol, 154, pp.787~803 (2006)
- Cooper DS, "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 16, pp.109~142 (2006)
- Duntas LH, "Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences", Eur J Endocrinol, 156, pp.13~19 (2007)
- Flynn RW, "Mortality and vascular outcomes in patients treated for thyroid dysfunction", J Clin Endocrinol Metab, 91, pp.2159~2164 (2006)
- Taddei S, "Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy", J Clin Endocrinol Metab, 88, pp.3731~3737 (2003)
- Erbil Y, "Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy", Br J Surg, 94, pp.1485~1490 (2007)
- Chang HJ, "Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test", Clin Cardiol, 27, pp.421~425 (2004)
- Corretti MC, "Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force", J Am Coll Cardiol, 39, pp.257~265 (2002)
- Fuster V, "Atherosclerosis, thrombosis, and vascular biology. In Cecil Textbook of Medicine. 22nd ed.", pp.383~389 (2004), Saunders
- Raitakari OT, "Flow-mediated dilatation", Br J Clin Pharmacol, 50, pp.397~404 (2000)
- Biondi B, "Hypothyroidism as a risk factor for cardiovascular disease", Endocrine, 24, pp.1~13 (2004)
- Suwaidi JA, "Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction", Circulation, 101, pp.948~954 (2000)
- Schächinger V, "Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease", Circulation, 101, pp.1899~1906 (2000)
- Papaioannou GI, "Treating hypothyroidism improves endothelial function", Metabolism, 53, pp.278~279 (2004)
- Monzani F, "Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism:a double-blind, placebo- controlled study", J Clin Endocrinol Metab, 89, pp.2099~2106 (2004)
- Owen PJ, "Subclinical hypothyroidism, arterial stiffness, and myocardial reserve", J Clin Endocrinol Metab, 91, pp.2126~2132 (2006)
- Owen PJ, "Thyroid disease and vascular function", Thyroid, 17, pp.519~524 (2007)
- Razvi S, "The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial", J Clin Endocrinol Metab, 92, pp.1715~1723 (2007)
- Botella-Carretero JI, "Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma", Endocr Relat Cancer, 11, pp.345~356 (2004)
- Di Paola R, "Left ventricular function in acute hypothyroidism: a Doppler echocardiography study", Ital Heart J, 5, pp.857~863 (2004)
- Regalbuto C, "Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer", J Endocrinol Invest, 29, pp.32~40 (2006)
- Guang-da X, "Changes in endotheliumdependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidism", Clin Endocrinol (Oxf), 61, pp.400~404 (2004)
- Botella-Carretero JI, "Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal", Thyroid, 16, pp.397~402 (2006)
- Warnholtz A, "Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study", Atherosclerosis, 204, pp.216~221 (2009)
- Miller VM, "Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk", Curr Vasc Pharmacol, 5, pp.15~25 (2007)
- Nagasaki T, "Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery", Biomed Pharmacother, 61, pp.167~172 (2007)
- Christ-Crain M, "Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A crosssectional and a double-blind, placebo-controlled trial", Atherosclerosis, 166, pp.379~386 (2003)
- Lee WY, "Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status", Arch Med Res, 35, pp.540~545 (2004)
- Pearce EN, "Thyroid function and lipid subparticle sizes in patients with shortterm hypothyroidism and a population-based cohort", J Clin Endocrinol Metab, 93, pp.888~894 (2008)